Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 1 hour ago

Binance to resume withdrawals after covering bulk of stolen $6.3 billion

Investing.com

stocksabout 4 hours ago

AI investors rush to hedge against potential tech market downturn - WSJ

Investing.com

stocksabout 5 hours ago

Hanwha signs $269 million shipbuilding contract for US Navy

Investing.com